Cyanosis surgery
Cyanosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cyanosis surgery On the Web |
American Roentgen Ray Society Images of Cyanosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Cardiac defect causing central cyanosis include Transposition of the great arteries, Tetralogy of fallot, Tricuspid atresia, Truncus arteriosus,Total anomalous pulmonary venous connection, Ebstein anomaly, critical Pulmonary stenosis or atresia, functional single ventricle. The palliative surgical shunt maybe done in such lesions to increase pulmonary blood flow even in the presence of cyanosis. Complete repair procedure leads to relief of cyanosis and shunt and also has long term complications.
Recommendation for surgery in cyanotic heart disease
The table shows indications for surgery in cyanotic congenital heart disease according to 2018 AHA/ACC Guideline:[1]
Abbreviations:
d-TGA: dextro-Transposition of great arteries;
PDA: Patent ductus arteriosus ;
ASD: Atrial septal defect;
VSD: Ventricular septal defect;
TAPVC: Total anomalous pulmonary venous connection;
TOF: Tetralogy of fallot;
CCTGA: Congenitally corrected transposition of the great arteries;
PS: Pulmonary stenosis;
AF: Atrial fibrillation;
VF: Ventricular fibrillation;
PR: Pulmonary regurgitation;
RVOT: Right ventricular outflow tract;
CMR: Cardiovascular magnetic resonance;
SVC: Superior vena cava;
IVC: Inferior vena cava;
Recommendation for surgery in cyanotic congenital heart disease |
Indications for repair of a scimitar vein in Anomalous pulmonary venous connection (TAPVC) (Class I, Level of Evidence B ): |
❑ Decreased functional capacity |
Indications for surgery in Anomalous Pulmonary Venous Connections (TAPVC)(Class 2a, Level of Evidence B) : |
❑ Asymptomatic adults with right ventricle volume overload |
Indications for surgical repair or reoperation in Ebstein anomaly : (Class I, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indications for surgical repair or reoperation in Ebstein anomaly:(Class 2a, Level of Evidence B) |
❑ Significant tricuspid regurgitation in the presence of the following: |
Indication for Glenn anastomousis at the time of repair in Ebstein anomaly : (Class 2b, Level of Evidence B) |
❑ Severe right ventricle dilation |
Indication for pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot (Class I, Level of Evidence B): |
❑ Symptomatic Moderate to severe pulmonary regurgitation after repaired TOF in which symptoms can not be explained otherwise. |
Indication for Pulmonary valve replacement ( surgical or percutaneous in Tetralogy of fallot : (Class 2a, Level of Evidence B) |
❑ Asymptomatic moderate to severe pulmonary regurgitation after repaired TOF |
Indication for Pulmonary valve replacement (surgical) in Tetralogy of fallot : (Class 2b, Level of Evidence C) |
❑ Moderate to severe PR with other lesions requiring surgery in repaired TOF |
Indication for Tricuspid valve replacement in CCTGA : (Class I, Level of Evidence B) |
❑ Symptomatic severe tricuspid regurgitaion accompanied by preserved or mildly systolic dysfunction of systemic ventricle |
Indication for Tricuspid valve replacement in CCTGA : (Class 2a, Level of Evidence C) |
❑ Asymptomatic severe tricuspid regurgitation accompanied by mildly dilated systemic ventricle |
Indication for conduit intervention/replacement in CCTGA : (Class 2b, Level of Evidence B) |
❑ Symptomatic subpulmonary left ventricle to pulmonary artery conduit dysfunction |
Indication for Balloon valvoplasty in Pulmonary stenosis : (Class I , Level of Evidence B) |
❑ In adult with moderate to severe valvular PS with symptoms of heart failure, cyanosis from intracardiac right to left shunt, exercise intolerance |
Indication for Balloon valvoplasty in Pulmonary Stenosis : (Class 2a , Level of Evidence C) |
❑ Asymptomatic severe valvular PS |
Indication for Dilation and Stenting in Peripheral Pulmonary Stenosis : (Class 2a, Level of Evidence B) |
❑ In adult with branch and peripheral PS , pulmonary artery dilation and stenting is recommended |
Surgical procedures in d-TGA and Tricuspid Atresia
Surgical management in d-TGA | Surgical management in Tricuspid Atresia |
---|---|
Life-saving balloon atrial septostomy in neonatal period | Blalock Taussig shunt |
Connection between right and the left system is necessary for the life |
|
Atrial switch procedure | Pulmonary artery banding.[3] |
Definition: Aorta arises from right ventricle and pulmonary artery arises from left ventricle |
|
Arterial switch procedure | Bidirectional Glenn shunt |
|
|
Rastelli procedure | Fontan procedure[4] |
|
|
Palliative Systemic-to-Pulmonary shunts
Arterial |
---|
Blalock-taussing-Thomas shunt ( subclavian artery to pulmonary artery) |
Central shunt ( aorta to pulmonary artery) |
Potts shunt (descending aorta to left pulmonary artery |
Waterston shunt( Ascending aorta to right pulmonary artery) |
Venous |
Glenn shunt ( SVC to the ipsilateral pulmonary artery ) |
Bidirectional cavopulmonary (Glenn) shunt( end to side SVC to left pulmonary artery and right pulmonary artery shunt) |
- Right ventricle–to-PA conduits is recommended in severe RVOT obstruction such as pulmonary atresia.
- theses conduits may be homografts or prosthetic conduits with bioprosthetic valves using within the conduit.
- Common complications of the conduits may include the following:
- Kinking
- Aneurysmal dilation
- Conduit dysfunction over time
- Progressive stenosis within the conduit or at the valve
- Valvular regurgitation
References
- ↑ Stout, Karen K.; Daniels, Curt J.; Aboulhosn, Jamil A.; Bozkurt, Biykem; Broberg, Craig S.; Colman, Jack M.; Crumb, Stephen R.; Dearani, Joseph A.; Fuller, Stephanie; Gurvitz, Michelle; Khairy, Paul; Landzberg, Michael J.; Saidi, Arwa; Valente, Anne Marie; Van Hare, George F. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 139 (14). doi:10.1161/CIR.0000000000000603. ISSN 0009-7322.
- ↑ Aykanat A, Yavuz T, Özalkaya E, Topçuoğlu S, Ovalı F, Karatekin G (January 2016). "Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease". Pediatr Cardiol. 37 (1): 131–4. doi:10.1007/s00246-015-1251-0. PMID 26260095.
- ↑ Boucek DM, Qureshi AM, Goldstein BH, Petit CJ, Glatz AC (January 2019). "Blalock-Taussig shunt versus patent ductus arteriosus stent as first palliation for ductal-dependent pulmonary circulation lesions: A review of the literature". Congenit Heart Dis. 14 (1): 105–109. doi:10.1111/chd.12707. PMID 30811802.
- ↑ Norwood WI, Jacobs ML (November 1993). "Fontan's procedure in two stages". Am. J. Surg. 166 (5): 548–51. doi:10.1016/s0002-9610(05)81151-1. PMID 8238751.